MedKoo Cat#: 124808 | Name: Dazdotuftide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Dazdotuftide is a novel, small synthetic molecule. It is a peptide conjugate comprised of tuftsin and phosphorylcholine that are covalently attached. The phosphorylcholine (PPC) moiety is based on a sequence from helminths’ secretory molecules which has been shown to be responsible for their immunoregulatory functions. Dazdotuftide and its components demonstrated in various autoimmune animal models and in vitro test systems its inhibitory effect on TLR-4 (inhibition of NfKb cascade), NRP-1 (inhibition of VEGF 165), and ACE2

Chemical Structure

Dazdotuftide
Dazdotuftide
CAS#2522933-44-2

Theoretical Analysis

MedKoo Cat#: 124808

Name: Dazdotuftide

CAS#: 2522933-44-2

Chemical Formula: C43H68N13O13P

Exact Mass: 1005.4800

Molecular Weight: 1006.07

Elemental Analysis: C, 51.34; H, 6.81; N, 18.10; O, 20.67; P, 3.08

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Dazdotuftide; TRS01; TRS-01; 8V4LO73JNW; 2522933-44-2
IUPAC/Chemical Name
4-((5-(2-carboxy-2-(2-(5-((diaminomethylene)amino)-2-(1-(threonyllysyl)pyrrolidine-2-carboxamido)pentanamido)acetamido)ethyl)-2-hydroxyphenyl)diazenyl)phenyl (2-(trimethylammonio)ethyl) phosphate
InChi Key
VXUMKMXYKWBBDK-UHFFFAOYSA-N
InChi Code
InChI=1S/C43H68N13O13P/c1-26(57)37(45)40(62)52-31(9-5-6-18-44)41(63)55-20-8-11-34(55)39(61)51-30(10-7-19-48-43(46)47)38(60)49-25-36(59)50-33(42(64)65)24-27-12-17-35(58)32(23-27)54-53-28-13-15-29(16-14-28)69-70(66,67)68-22-21-56(2,3)4/h12-17,23,26,30-31,33-34,37,57H,5-11,18-22,24-25,44-45H2,1-4H3,(H10-,46,47,48,49,50,51,52,53,58,59,60,61,62,64,65,66,67)
SMILES Code
CC(C(C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC2=CC(=C(C=C2)O)N=NC3=CC=C(C=C3)OP(=O)([O-])OCC[N+](C)(C)C)C(=O)O)N)O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,006.07 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Vofo BN, Chowers I. Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate. Biomedicines. 2023 May 27;11(6):1562. doi: 10.3390/biomedicines11061562. PMID: 37371657; PMCID: PMC10295757.